0874.HKライブシグナル | Getagraph.comで利益を最大化

Live Chart Being Loaded With Signals

Commentary (2 5月 2024 @ 17:08):

Stats
本日の出来高	286 000
平均出来高	784 541
時価総額	54.17B
EPS	HKD0.600 ( 2023-10-30 )
Last Dividend	HKD0.813 ( 2023-06-14 )
Next Dividend	HKD0 ( N/A )
P/E	8.02
ATR14	HKD0.0460 (0.21%)

ボリューム相関

長: -0.19 (neutral)

短: 0.88 (strong)

Signal:(77.304) Same movement expected

Guangzhou Baiyunshan 相関

10 最も正の相関

10 最も負の相関

知っていましたか？

相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関（1つの変数が増加すると、もう一方は減少する）、1は完全な正の相関（1つの変数が増加すると、もう一方も増加する）、0は相関がないことを示します（変数間に関係がない）。

相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。

Guangzhou Baiyunshan 相関 - 通貨/商品

0.43
( neutral )

0.31
( neutral )

0.82
( strong )

0.57
( weak )

-0.45
( neutral )

-0.50
( weak negative )

Guangzhou Baiyunshan 財務諸表

Annual	2023
収益:	HKD75.52B
総利益:	HKD14.19B (18.79 %)
EPS:	HKD2.50

FY	2023
収益:	HKD75.52B
総利益:	HKD14.19B (18.79 %)
EPS:	HKD2.50

FY	2022
収益:	HKD70.79B
総利益:	HKD13.28B (18.76 %)
EPS:	HKD2.44

FY	2021
収益:	HKD69.01B
総利益:	HKD13.23B (19.17 %)
EPS:	HKD2.29

Financial Reports:

No articles found.

Guangzhou Baiyunshan Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0.813 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)

Guangzhou Baiyunshan Dividend Information - Ex Dividend Knight

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 5.46 - Stable (9.21%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	HKD0.0300	2000-04-20
Last Dividend	HKD0.813	2023-06-14
Next Dividend	HKD0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	25	--
Total Paid Out	HKD6.04	--
Avg. Dividend % Per Year	0.00%	--
Score	3.29	--
Div. Sustainability Score	10.00
Div.Growth Potential Score	5.46
Div. Directional Score	8.47	--

Next Divdend (Est)
(2025-02-21)

HKD0.870 Estimate 3.15 %

Dividend Stability

0.25 Very Poor

Dividend Score

3.29

Pay Frequency

Annually

Yearly Payout

Year	Amount	Yield

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for HKSE

Symbol	Title	Last dividend	Frequency	Yearly Dividend
2378.HK	Ex Dividend Knight	2023-09-07	Semi-Annually	0.00%
1359.HK	Ex Dividend Junior	2023-06-26	Annually	0.00%
0405.HK	Ex Dividend Junior	2023-09-12	Semi-Annually	0.00%
6806.HK	Ex Dividend Knight	2023-06-26	Annually	0.00%
1908.HK	Ex Dividend Junior	2023-06-01	Sporadic	0.00%
0941.HK	Ex Dividend Knight	2023-09-01	Semi-Annually	0.00%
0064.HK	Ex Dividend Knight	2023-08-29	Semi-Annually	0.00%
2888.HK	Ex Dividend Junior	2023-08-10	Annually	0.00%
1508.HK	Ex Dividend Junior	2023-06-29	Annually	0.00%
0558.HK	Ex Dividend Junior	2023-09-12	Annually	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.0534	1.500	8.93	10.00	[0 - 0.5]
returnOnAssetsTTM	0.0522	1.200	8.26	9.91	[0 - 0.3]
returnOnEquityTTM	0.117	1.500	9.81	10.00	[0.1 - 1]
payoutRatioTTM	0.383	-1.000	6.17	-6.17	[0 - 1]
currentRatioTTM	1.640	0.800	6.80	5.44	[1 - 3]
quickRatioTTM	1.302	0.800	7.05	5.64	[0.8 - 2.5]
cashRatioTTM	0.579	1.500	7.89	10.00	[0.2 - 2]
debtRatioTTM	0.175	-1.500	7.08	-10.00	[0 - 0.6]
interestCoverageTTM	11.84	1.000	6.73	6.73	[3 - 30]
operatingCashFlowPerShareTTM	4.27	2.00	8.58	10.00	[0 - 30]
freeCashFlowPerShareTTM	3.22	2.00	8.39	10.00	[0 - 20]
debtEquityRatioTTM	0.374	-1.500	8.50	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.185	1.000	-0.246	-0.246	[0.2 - 0.8]
operatingProfitMarginTTM	0.0679	1.000	-0.641	-0.641	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.503	1.000	8.32	8.32	[0.2 - 2]
assetTurnoverTTM	0.976	0.800	6.83	5.46	[0.5 - 2]
Total Score				11.49

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	7.63	1.000	9.33	0	[1 - 100]
returnOnEquityTTM	0.117	2.50	9.88	10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	3.22	2.00	8.93	10.00	[0 - 30]
dividendYielPercentageTTM	4.22	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	4.27	2.00	8.58	10.00	[0 - 30]
payoutRatioTTM	0.383	1.500	6.17	-6.17	[0 - 1]
pegRatioTTM	0.126	1.500	-2.49	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.0904	1.000	-0.241	0	[0.1 - 0.5]
Total Score				5.46

Guangzhou Baiyunshan

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited, together with its subsidiaries, engages in the research, development, manufacture, and sale of Chinese patent and Western medicines, chemical raw materials, natural and biological medicines, and intermediates of chemical raw materials in the People's Republic of China and internationally. The company operates through four segments: Great Southern TCM, Great Commerce, Great Health, and Others. It is also involved in the wholesale, retail, import, and export of Western and Chinese medicines, and medical apparatus and instruments; and research and development, production, and sale of beverages, food, healthcare products, pre-packaging food, dairy products, tablets, capsules, lozenges, injections, tortoise herb jelly, etc. In addition, the company invests in health industry, such as medical care, health management, health preservation, elderly care, etc.; and provides commercial and advertising services. As of December 31, 2021, it had 154 retail chain pharmacy outlets, which included 22 Cai Zhi Lin pharmacy outlets, 36 Jian Min pharmacy outlets, 51 GPC Prescription Pharmacy outlets, and 23 Hainan Guangyao Chenfei Pharmaceutical Chain Co., Ltd outlets, as well as 22 retail stores. The company was formerly known as Guangzhou Pharmaceutical Company Limited and changed its name to Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited in August 2013. Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited was incorporated in 1997 and is based in Guangzhou, China.